Protara Therapeutics (TARA) Treasury Shares (2013 - 2014)

Protara Therapeutics (TARA) has reported Treasury Shares for 6 consecutive years, with $571145.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Treasury Shares rose 93.01% year-over-year to $571145.0; the TTM figure through Dec 2025 stood at $571145.0 (up 93.01% YoY), while the FY2025 annual figure was $571145.0, up 93.01% from the prior year.
• Treasury Shares grew to $571145.0 in Q4 2025 per TARA's latest filing, from $555245.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $571145.0 in Q4 2025 and bottomed at $196838.0 in Q4 2022.
• Historically, Treasury Shares has averaged $368608.2 across 4 years, with a median of $319404.5 in 2024.
• On a YoY basis, Treasury Shares climbed as much as 93.01% in 2025 and fell as far as 12.16% in 2025.
• Protara Therapeutics' Treasury Shares stood at $196838.0 in 2022, then grew by 20.24% to $236679.0 in 2023, then advanced by 25.03% to $295914.0 in 2024, then surged by 93.01% to $571145.0 in 2025.
• Business Quant data shows TARA's Treasury Shares at $571145.0 in Q4 2025, $555245.0 in Q3 2025, and $510945.0 in Q2 2025.